Literature DB >> 22123850

mRNA translation and energy metabolism in cancer: the role of the MAPK and mTORC1 pathways.

I Topisirovic1, N Sonenberg.   

Abstract

mRNA translation is the most energy-consuming process in the cell and strongly correlates with cellular metabolic activity. Translation and energy metabolism play important roles in homeostatic cell growth and proliferation, and when dysregulated lead to cancer. eIF4E is a key regulator of translation, which promotes oncogenesis by selectively enhancing translation of a subset of tumor-promoting mRNAs (e.g., cyclins and c-myc). PI3K/AKT and mitogen-activated protein kinase (MAPK) pathways, which are strongly implicated in cancer etiology, exert a number of their biological effects by modulating translation. The PI3K/AKT pathway regulates eIF4E function by inactivating the inhibitory 4E-BPs via mTORC1, whereas MAPKs activate MAP kinase signal-integrating kinases 1 and 2, which phosphorylate eIF4E. In addition, AMP-activated protein kinase, which is a central sensor of the cellular energy balance, impairs translation by inhibiting mTORC1. Thus, eIF4E plays a major role in mediating the effects of PI3K/AKT, MAPK, and cellular energetics on mRNA translation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123850     DOI: 10.1101/sqb.2011.76.010785

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  41 in total

Review 1.  uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.

Authors:  Hung-Hsi Chen; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2019-06-24       Impact factor: 4.652

2.  Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.

Authors:  John T Cunningham; Melissa V Moreno; Alessia Lodi; Sabrina M Ronen; Davide Ruggero
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 3.  Commonalities between pain and memory mechanisms and their meaning for understanding chronic pain.

Authors:  Theodore J Price; Kufreobong E Inyang
Journal:  Prog Mol Biol Transl Sci       Date:  2015-01-30       Impact factor: 3.622

Review 4.  FXR1a-associated microRNP: A driver of specialized non-canonical translation in quiescent conditions.

Authors:  Syed I A Bukhari; Shobha Vasudevan
Journal:  RNA Biol       Date:  2016-12-02       Impact factor: 4.652

5.  Generally applicable transcriptome-wide analysis of translation using anota2seq.

Authors:  Christian Oertlin; Julie Lorent; Carl Murie; Luc Furic; Ivan Topisirovic; Ola Larsson
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

6.  Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.

Authors:  Richard Y Ebright; Sooncheol Lee; Ben S Wittner; Kira L Niederhoffer; Benjamin T Nicholson; Aditya Bardia; Samuel Truesdell; Devon F Wiley; Benjamin Wesley; Selena Li; Andy Mai; Nicola Aceto; Nicole Vincent-Jordan; Annamaria Szabolcs; Brian Chirn; Johannes Kreuzer; Valentine Comaills; Mark Kalinich; Wilhelm Haas; David T Ting; Mehmet Toner; Shobha Vasudevan; Daniel A Haber; Shyamala Maheswaran; Douglas S Micalizzi
Journal:  Science       Date:  2020-02-06       Impact factor: 47.728

7.  Ribosome Profiling Reveals Translational Upregulation of Cellular Oxidative Phosphorylation mRNAs during Vaccinia Virus-Induced Host Shutoff.

Authors:  Aimei Dai; Shuai Cao; Pragyesh Dhungel; Yizhao Luan; Yizhi Liu; Zhi Xie; Zhilong Yang
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

Review 8.  Developing anti-neoplastic biotherapeutics against eIF4F.

Authors:  Jutta Steinberger; Jennifer Chu; Rayelle Itoua Maïga; Katia Sleiman; Jerry Pelletier
Journal:  Cell Mol Life Sci       Date:  2016-12-21       Impact factor: 9.261

Review 9.  Targeting the translation machinery in cancer.

Authors:  Mamatha Bhat; Nathaniel Robichaud; Laura Hulea; Nahum Sonenberg; Jerry Pelletier; Ivan Topisirovic
Journal:  Nat Rev Drug Discov       Date:  2015-03-06       Impact factor: 84.694

10.  Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.

Authors:  Shalini Jain; Xiao Wang; Chia-Chi Chang; Catherine Ibarra-Drendall; Hai Wang; Qingling Zhang; Samuel W Brady; Ping Li; Hong Zhao; Jessica Dobbs; Matt Kyrish; Tomasz S Tkaczyk; Adrian Ambrose; Christopher Sistrunk; Banu K Arun; Rebecca Richards-Kortum; Wei Jia; Victoria L Seewaldt; Dihua Yu
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.